Literature DB >> 30116603

Atypical antibody responses to influenza.

Dalton Hermans1, Richard J Webby2, Sook-San Wong2.   

Abstract

Influenza viruses undergo rapid antigenic evolution and reassortment, resulting in annual epidemics and the occasional pandemics. Exposure to influenza virus hemagglutinin (HA) and neuraminidase (NA) antigen, either through vaccination or infection, induces an antibody response able to recognize only the homologous antigenic subtype. However, atypical antibody responses recognizing non-homologous influenza subtypes have been reported during infection and vaccination. Here, we review the incidence of these phenomena in published literature and discuss the potential mechanisms underlying them.

Entities:  

Keywords:  Influenza; antibody; heterosubtypic; neutralizing

Year:  2018        PMID: 30116603      PMCID: PMC6072921          DOI: 10.21037/jtd.2017.12.122

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  50 in total

Review 1.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

2.  Immunogenic structure of the influenza virus hemagglutinin.

Authors:  N Green; H Alexander; A Olson; S Alexander; T M Shinnick; J G Sutcliffe; R A Lerner
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

3.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 4.  Influenza A and B co-infection: a case-control study and review of the literature.

Authors:  F Pérez-García; V Vásquez; V de Egea; P Catalán; B Rodríguez-Sánchez; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-15       Impact factor: 3.267

5.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

6.  Clinical features of influenza C virus infection in children.

Authors:  Yoko Matsuzaki; Noriko Katsushima; Yukio Nagai; Makoto Shoji; Tsutomu Itagaki; Michiyo Sakamoto; Setsuko Kitaoka; Katsumi Mizuta; Hidekazu Nishimura
Journal:  J Infect Dis       Date:  2006-03-31       Impact factor: 5.226

7.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Authors:  M Gordon Joyce; Adam K Wheatley; Paul V Thomas; Gwo-Yu Chuang; Cinque Soto; Robert T Bailer; Aliaksandr Druz; Ivelin S Georgiev; Rebecca A Gillespie; Masaru Kanekiyo; Wing-Pui Kong; Kwanyee Leung; Sandeep N Narpala; Madhu S Prabhakaran; Eun Sung Yang; Baoshan Zhang; Yi Zhang; Mangaiarkarasi Asokan; Jeffrey C Boyington; Tatsiana Bylund; Sam Darko; Christopher R Lees; Amy Ransier; Chen-Hsiang Shen; Lingshu Wang; James R Whittle; Xueling Wu; Hadi M Yassine; Celia Santos; Yumiko Matsuoka; Yaroslav Tsybovsky; Ulrich Baxa; James C Mullikin; Kanta Subbarao; Daniel C Douek; Barney S Graham; Richard A Koup; Julie E Ledgerwood; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola; Adrian B McDermott
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

8.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.

Authors:  Mark I Chen; Ian G Barr; Gerald C H Koh; Vernon J Lee; Caroline P S Lee; Robert Shaw; Cui Lin; Jonathan Yap; Alex R Cook; Boon Huan Tan; Jin Phang Loh; Timothy Barkham; Vincent T K Chow; Raymond T P Lin; Yee-Sin Leo
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

10.  Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009.

Authors:  Matthew Peacey; Richard J Hall; Stephanie Sonnberg; Mariette Ducatez; Shevaun Paine; Mackenzie Nicol; Jacqui C Ralston; Don Bandaranayake; Virginia Hope; Richard J Webby; Sue Huang
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

View more
  2 in total

1.  Alveolar macrophage-derived extracellular vesicles inhibit endosomal fusion of influenza virus.

Authors:  Daniel J Schneider; Katherine A Smith; Catrina E Latuszek; Carol A Wilke; Danny M Lyons; Loka R Penke; Jennifer M Speth; Matangi Marthi; Joel A Swanson; Bethany B Moore; Adam S Lauring; Marc Peters-Golden
Journal:  EMBO J       Date:  2020-07-09       Impact factor: 11.598

2.  Antibody responses to influenza A(H1N1)pdm infection.

Authors:  Steph Wraith; Raffael Nachbagauer; Angel Balmaseda; Daniel Stadlbauer; Sergio Ojeda; Arvind Rajabhathor; Roger Lopez; Andrea F Guglia; Nery Sanchez; Fatima Amanat; Lionel Gresh; Guillermina Kuan; Florian Krammer; Aubree Gordon
Journal:  Vaccine       Date:  2020-05-07       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.